Molecular Diagnostic Testing and Techniques for Emerging Mutations (On-Demand)
: 2 Sep 2021 - 1 Jan 2022
This webinar focuses on the impact of molecular diagnostic testing and techniques on identifying mutations involved in emerging SARS-CoV-2 variants.
First, Dr. Alan McNally shares how B.1.1.7 was discovered in the UK, highlights the role played by a molecular diagnostic assay in its detection and discusses design principles that aid in the development of effective and robust molecular diagnostic assays.
In the second part, Dr. Emmanuel André discusses an approach to identifying specific SARS-CoV-2 variants using a targeted mutation panel as a follow-up test, and he provides details as well as advantages of using this approach for wide-scale SARS-CoV-2 surveillance.